PofoliaShared via Pofolia

Skeletal Radiology· 2026Q2

Spiradenocarcinoma in Brooke–Spiegler syndrome: radiology-pathology correlation of synchronous benign and malignant dermal adnexal tumors

Vineet Vijay Gorolay, Alison J. Potter, Lisa C. Worgan, Sydney Ch’ng et al.

Short summary

Rapid growth and high FDG avidity (SUVmax 16.3) on PET-CT can help differentiate rare spiradenocarcinoma from benign spiradenoma in patients with Brooke-Spiegler Syndrome (BSS).

AI-generated from the title and abstract; the full text is not read.

Key points

  • A patient with Brooke-Spiegler Syndrome (BSS) had synchronous benign spiradenoma and malignant spiradenocarcinoma.
  • MRI showed heterogeneous enhancement and reduced diffusion in both lesions.
  • PET-CT revealed markedly higher FDG avidity (SUVmax 16.3) in the malignant spiradenocarcinoma versus mild uptake (SUVmax 2.1) in the benign spiradenoma.
  • Rapid growth and high FDG avidity are potential radiological indicators to distinguish spiradenocarcinoma from spiradenoma in BSS patients.

AI-generated from the title and abstract; the full text is not read.

Abstract

Abstract Spiradenocarcinoma is a rare dermal adnexal malignancy often arising from a pre-existing benign spiradenoma and may occur sporadically or in the setting of the autosomal dominant genodermatosis Brooke–Spiegler Syndrome (BSS). Imaging descriptions of spiradenoma and spiradenocarcinoma are scant, with no literature to date describing comparative imaging features of benign and malignant tumors to the best of our knowledge. We report a case of a 64-year-old patient with a rapidly enlarging right frontal scalp mass and a relatively indolent left parietal scalp mass in addition to innumerable small head and neck nodules. MRI for preoperative planning demonstrated heterogeneous enhancement and markedly reduced diffusion in both lesions, while 18 F-FDG PET-CT showed marked FDG avidity (SUVmax = 16.3) in the frontal mass but mild uptake in the parietal mass (SUVmax = 2.1). Histopathology confirmed the frontal mass to be a low-grade spiradenocarcinoma and the left parietal lesion a benign spiradenoma. Genetic testing confirmed BSS. This case illustrates the clinical-radiologic-pathologic correlation of spiradenocarcinoma in the context of BSS, a rare clinical and radiologic mimic of NF1, and highlights that rapid growth and FDG avidity may help the reporting radiologist to differentiate spiradenocarcinoma from spiradenoma in patients with BSS.

The authors' abstract, as published at the source. Skeletal Radiology, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Dermatology

DermatologyMedicine